The North Louisiana Criminalistics Laboratory is warning the public after recent testing found that nearly one in three pharmaceutical-style tablets examined by the lab were counterfeit.
According to the crime lab, analysts examined 3,394 pharmaceutical tablets bearing legitimate drug imprints intended to identify the medication. Of those, 1,047 tablets were determined to be counterfeit, representing a counterfeit rate of 30.8%.
Lab officials said fentanyl and fentanyl analogs were the most commonly identified substances found in the counterfeit pills. Designer benzodiazepines, including bromazolam and phenazolam, were the second most common. Combined, those two drug classes accounted for approximately 80% of the counterfeit pills analyzed.
The remaining counterfeit tablets contained stimulants, other mismatched substances, and emerging novel opioids such as nitazenes and orphines.
According to the lab, the most frequently counterfeited pill was the M30 tablet, which is the imprint for legitimate 30-milligram oxycodone. Investigators also identified counterfeit versions of several alprazolam (Xanax) bar imprints, including S903, B707, GG249 and G3722, which instead contained designer benzodiazepines.
The crime lab said counterfeit pills have been identified throughout its 29-parish service area, including Ouachita, Caddo and Bossier parishes, as well as rural parishes such as Sabine, Lincoln, Morehouse and Winn.
Officials emphasized that it is impossible to determine what a pill contains based solely on its appearance and urged the public to only take medications dispensed by a licensed pharmacy with a valid prescription.
The North Louisiana Criminalistics Laboratory warned that any pill obtained outside of a pharmacy should be considered potentially lethal, noting that a single counterfeit pill can be fatal.
